Benefits of Screening
Screening reduces the risk of DKA and hospitalization at onset of symptoms.
DKA, a serious complication of T1D, can be life-threatening and studies show that the risk of DKA at diagnosis is significantly reduced for those screened for autoantibodies and monitored closely by a doctor, if positive.
Right now, promising clinical trials are testing therapies that could delay the onset of T1D for years after screening.
These potential therapies could hold off insulin dependency for up to three years, but only with early intervention which is possible thanks to screening.
Knowing your results gives peace of mind and time to prepare.
Many families feel blindsided by a T1D diagnosis. Knowing your autoantibody results before the onset of symptoms can give you time to prepare with your doctor and family.